The anti-tumor activity of an anti-CD39 antibody (ES002) in a multiple myeloma model is dependent on NK cells

被引：0

作者：

Qiu, Yangsheng ^{[1
]}

Du, Qinglin ^{[1
]}

Sun, Meiling ^{[1
]}

Gao, Rui ^{[1
]}

Kong, Huimin ^{[1
]}

Xing, Roumei ^{[1
]}

Shi, Yufei ^{[1
]}

Xu, Mengying ^{[1
]}

Wu, Zhihao ^{[1
]}

Lu, Hongtao ^{[1
]}

机构：

[1] Elpisci Biopharma, Shanghai, Peoples R China

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P790

引用

页数：1

共 50 条

[41] CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells
Qadir, Abdul S.
Guegan, Jean Philippe
Ginestier, Christophe
Chaibi, Assia
Bessede, Alban
Charafe-Jauffret, Emmanuelle
Macario, Manon
Lavoue, Vincent
Rouge, Thibault de la Motte
Law, Calvin
Vilker, Jacob
Wang, Hongbin
Stroup, Emily
Schipma, Matthew J.
Bridgeman, Bryan
Murmann, Andrea E.
Ji, Zhe
Legembre, Patrick
Peter, Marcus E.
ISCIENCE, 2021, 24 (11)
[42] Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
Jorge Schettini
Amritha Kidiyoor
Dahlia M. Besmer
Teresa L. Tinder
Lopamudra Das Roy
Joseph Lustgarten
Sandra J. Gendler
Pinku Mukherjee
Cancer Immunology, Immunotherapy, 2012, 61 : 2055 - 2065
[43] Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
Schettini, Jorge
Kidiyoor, Amritha
Besmer, Dahlia M.
Tinder, Teresa L.
Das Roy, Lopamudra
Lustgarten, Joseph
Gendler, Sandra J.
Mukherjee, Pinku
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) : 2055 - 2065
[44] Myeloma cells can corrupt senescent mesenchymal stromal cells and impair their anti-tumor activity
Ozcan, Servet
Alessio, Nicola
Acar, Mustafa Burak
Toprak, Guler
Gonen, Zeynep Burcin
Peluso, Gianfranco
Galderisi, Umberto
ONCOTARGET, 2015, 6 (37) : 39482 - 39492
[45] Phosphorylated STAT3 reflects anti-tumor activity of anti-IL-6 therapy in a mouse model of multiple myeloma.
Hanson, R
McCabe, F
Zaki, M
Nemeth, JA
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8982S - 8983S
[46] NK Cell Anti-Tumor Efficacy in Multiple Myeloma Patients Before and After Autologous Stem Cell Transplantation
Tognarelli, S.
von Metzler, I.
Rais, B.
Jacobs, B.
Bader, P.
Serve, H.
Mackensen, A.
Ullrich, E.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2017, 47 : 236 - 236
[47] Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
Li, Pan
Rozich, Noah
Wang, Jianxin
Wang, Junke
Xu, Yao
Herbst, Brian
Yu, Raymond
Muth, Stephen
Niu, Nan
Li, Keyu
Funes, Vanessa
Gai, Jessica
Osipov, Arsen
Edil, Barish H.
Wolfgang, Christopher L.
Lei, Ming
Liang, Tingbo
Zheng, Lei
CANCER LETTERS, 2022, 539
[48] Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma
Jakubikova, Jana
Cervi, David
Ooi, Melissa
Kim, Kihyun
Nahar, Sabikun
Klippel, Steffen
Cholujova, Dana
Leiba, Merav
Daley, John F.
Delmore, Jake
Negri, Joseph
Blotta, Simona
McMillin, Douglas W.
Hideshima, Teru
Richardson, Paul G.
Sedlak, Jan
Anderson, Kenneth C.
Mitsiades, Constantine S.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1170 - 1179
[49] Anti-tumor activity of the proteasome inhibitor BSc2118 against human multiple myeloma
Zang, Meirong
Li, Zengjun
Liu, Lanting
Li, Fei
Li, Xin
Dai, Yun
Li, Wei
Kuckelkorn, Ulrike
Doeppner, Thorsten R.
Hermann, Dirk M.
Zhou, Wen
Qiu, Lugui
Jin, Fengyan
CANCER LETTERS, 2015, 366 (02) : 173 - 181
[50] SO-C101 INDUCES NK CELL CYTOTOXICITY AND POTENTIATES ANTIBODY-DEPENDENT CELL CYTOTOXICITY AND ANTI-TUMOR ACTIVITY
Antosova, Zuzana
Podzimkova, Nada
Jiratova, Marketa
Nedvedova, Eva
De Martynoff, Guy
Bechard, David
Moebius, Ulrich
Spisek, Radek
Adkins, Irena
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A339 - A339

← 1 2 3 4 5 →